论文信息 - Enasidenib Monotherapy Is Effective and Well-Tolerated in Patients with Previously Untreated Mutant- IDH2 (m IDH2) Acute Myeloid Leukemia (AML) - 字舞流文

Enasidenib Monotherapy Is Effective and Well-Tolerated in Patients with Previously Untreated Mutant- IDH2 (m IDH2) Acute Myeloid Leukemia (AML)

R. Collins | H. Kantarjian | M. Tallman | C. Dinardo | D. Pollyea | S. Agresta | S. Botton | E. Stein | A. Stein | Qiang Xu | I. Gupta | A. Tosolini